Provided by Tiger Fintech (Singapore) Pte. Ltd.

Apellis Pharmaceuticals Inc.

18.03
-0.1700-0.93%
Post-market: 18.800.7700+4.27%18:13 EDT
Volume:1.79M
Turnover:32.42M
Market Cap:2.26B
PE:-11.29
High:18.72
Open:18.00
Low:17.68
Close:18.20
Loading ...
Apr 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities